» Authors » Lydia L Shook

Lydia L Shook

Explore the profile of Lydia L Shook including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 1618
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Packer C, Jasset O, Hanniford N, Brigida S, Demidkin S, Perlis R, et al.
Front Immunol . 2025 Jan; 15:1506203. PMID: 39845965
Objective: Vaccination is protective against severe COVID-19 disease, yet whether vaccination reduces COVID-19-associated inflammation in pregnancy has not been established. The objective of this study is to characterize maternal and...
2.
Oh D, Kim E, Normand R, Lu G, Shook L, Lyall A, et al.
Cell Rep . 2024 Nov; 43(11):114933. PMID: 39504241
Pregnancy is a risk factor for increased severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other respiratory infections, but the mechanisms underlying this risk are poorly understood. To...
3.
Ockene M, Balaguru D, Ma I, Russo S, Arpante A, Clifford A, et al.
Open Forum Infect Dis . 2024 Jun; 11(6):ofae305. PMID: 38933738
The intrauterine environment plays a critical role in shaping chronic disease risk over the life course. We prospectively evaluated cardiometabolic outcomes in toddlers born to mothers with versus without prenatal...
4.
Shook L, Batorsky R, De Guzman R, McCrea L, Brigida S, Horng J, et al.
J Neuroinflammation . 2024 Jun; 21(1):163. PMID: 38918792
Background: The SARS-CoV-2 virus activates maternal and placental immune responses. Such activation in the setting of other infections during pregnancy is known to impact fetal brain development. The effects of...
5.
Clapp M, Castro V, Verhaak P, McCoy T, Shook L, Edlow A, et al.
medRxiv . 2024 Jun; PMID: 38854098
Objective: Postpartum depression (PPD) represents a major contributor to postpartum morbidity and mortality. Beyond efforts at routine screening, risk stratification models could enable more targeted interventions in settings with limited...
6.
Batorsky R, Ceasrine A, Shook L, Kislal S, Bordt E, Devlin B, et al.
Cell Rep . 2024 Jun; 43(6):114326. PMID: 38848212
Maternal immune activation is associated with adverse offspring neurodevelopmental outcomes, many mediated by in utero microglial programming. As microglia remain inaccessible throughout development, identification of noninvasive biomarkers reflecting fetal brain...
7.
Lopez P, Nziza N, Chen T, Shook L, Burns M, Demidkin S, et al.
iScience . 2024 Mar; 27(3):109273. PMID: 38444609
Completion of a COVID-19 vaccination series during pregnancy effectively reduces COVID-19 hospitalization among infants less than 6 months of age. The dynamics of transplacental transfer of maternal vaccine-induced antibodies, and...
8.
Oh D, Kim E, Lu G, Normand R, Shook L, Lyall A, et al.
medRxiv . 2024 Feb; PMID: 38370801
Pregnancy is a risk factor for increased severity of SARS-CoV-2 and other respiratory infections. The mechanisms underlying this risk have not been well-established, partly due to a limited understanding of...
9.
Shook L, Castro V, Herzberg E, Fourman L, Kaimal A, Perlis R, et al.
Obesity (Silver Spring) . 2024 Feb; 32(5):969-978. PMID: 38351665
Objective: The objective of this study is to determine whether in utero exposure to SARS-CoV-2 is associated with increased risk for a cardiometabolic diagnosis by 18 months of age. Methods:...
10.
Shook L, Batorsky R, De Guzman R, McCrea L, Brigida S, Horng J, et al.
medRxiv . 2024 Jan; PMID: 38234776
The SARS-CoV-2 virus activates maternal and placental immune responses, which in the setting of other infections occurring during pregnancy are known to impact fetal brain development. The effects of maternal...